Subgroup analysis can further help us determine the predictive efficacy of GPX8 in specific populations, which indicates that a high expression of GPX8 represents a worse prognosis in the following patients: patients without distant metastasis, patients with tumor invading the serosal layer, or patients with poorly differentiated tissue. This evidence concerns the gene GPX8 and neoplasm.